Inotek Pharmaceuticals (ITEK) Priced

Biotech developing a small molecule eye drop therapy to treat glaucoma.

Health Care - Biotechnology

IPO Performance
Latest Trade $1.63 0.00 (0.0%)
First Day Return 0.0%
Return from IPO -72.9%
 
Inotek Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 11/05/2014
Offer Price $6.00
Price Range $6.00 - $6.00
Offer Shares (mm) 6.7
Deal Size ($mm) 40
 
IPO Data
IPO Date 02/17/2015
Offer Price $6.00
Price Range $6.00 - $6.00
Offer Shares (mm) 6.7
Deal Size ($mm) $40
 
Underwriters
more
Business Overview
Biotech developing a small molecule eye drop therapy to treat glaucoma.
Biotech developing a small molecule eye drop therapy to treat glaucoma.
more
Company Data
Headquarters Lexington, MA
Founded 1999
Employees 4
Website www.inotekpharma.com
 

Performance vs. IPO Index (IPOUSA)